Rivus to show animal data on muscle-sparing GLP-1

Coverage, in order

1. 12d ago
   
   Longevity.Technology UK indie study

   Rivus to show animal data on muscle-sparing GLP-1

   The preclinical results for RV-8451, an oral GLP-1 pill, will go on display as three posters at ObesityWeek in Washington, DC, in November. If you sat down to write a wish list for a weight-loss drug, a pill that goes after fat and leaves muscle alone would probably land near the top. Rivus…

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.